A 52-week repeated dose toxicity study of ultraviolet absorber 2-(2′-hydroxy-3′,5′-di-tert-butylphenyl)benzotriazole in rats

Drug and Chemical Toxicology

Volumn 31, Issue 1, 2008, Pages 81-96

  Hirata Koizumi, Mutsuko ^a   Ogata, Hidehiro ^b   Imai, Toshio ^a   Hirose, Akihiko ^a   Kamata, Eiichi ^a   Ema, Makoto ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Panapharm Laboratories Co Ltd   (Japan)

Author keywords

Benzotriazole UV absorber; Chronic toxicity; Gender related difference; Rat

Indexed keywords

2 (2' HYDROXY 3',5' DI TERT BUTYLPHENYL)BENZOTRIAZOLE; ALKALINE PHOSPHATASE; BENZOTRIAZOLE DERIVATIVE; GLUCOSE; LIPOFUSCIN; SEX HORMONE; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CELL DEATH; CELL DEGENERATION; CHRONIC TOXICITY; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HISTOPATHOLOGY; INFERIOR CAVA VEIN; LIVER CELL; LIVER HYPERTROPHY; LIVER WEIGHT; MALE; NONHUMAN; RAT; SEX DIFFERENCE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; HEART; LIVER; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TIME FACTORS; TOXICITY TESTS, CHRONIC; TRIAZOLES; ULTRAVIOLET RAYS;

RATTUS;

EID: 37649010254     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540701688758     Document Type: Article

References (22)

1. Bartlett, M. S. (1937). Properties of sufficiency and statistical tests. Proc. R. Soc. Lond. Ser. A 160:268-282.
2. Blaauboer, B. J., van Holsteijn, C. W., Bleumink, R., Mennes, W. C., van Pelt, F. N., Yap, S. H., van Pelt, J. F., van Iersel, A. A., Timmerman, A., Schmid, B. P. (1990). The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey, and human hepatocytes. Biochem. Pharmacol. 40:521-528.
3. Cattley, R. C., Popp, J. A. (2002). Liver. In Haschek, W. M., Rousseaux, C. G., Wallig, M.A., (eds.)., Handbook of Toxicologic Pathology, 2nd ed. Vol. 2. San Diego: Academic Press, pp. 187-225.
4. Commerce Online. (2007). Product Keywords on Wujiang Dongfeng Chemical Co., Ltd. Accessed on April 25, 2007 from http://www.commerce.com.tw/ company_inside.php?ID=C0013309.
5. Dunnett, C. W. (1964). New tables for multiple comparisons with a control. Biometrics 20:482-491.
6. EA, MHW and MITI (Environment Agency, Ministry of Health and Welfare, and Ministry of International Trade and Industry of Japan). (2000). "Testing Facility Provided in the Article 4 in the Ordinance Prescribing Test Relating to New Chemical Substances and Toxicity Research of Designated Chemical Substances," Planning and Coordination Bureau, Environment Agency No. 41 and Environmental Health Bureau, Ministry of Health and Welfare No. 268, dated March 1, 2000, and Basic Industries Bureaus, Ministry of International Trade and Industry No. 1, dated February 14, 2000.
7. Elcombe, C. R., Mitchell, A. M. (1986). Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ. Health Perspect. 70:211-219.
8. Fisher, R. A. (1973). Statistical Methods of Research Workers, 14th ed.New York: Hapner Publishing Company, p. 6.
9. Glaister, J. R. (1992). Histopathology of target organs - cardiovascular. In Principles of Toxicological Pathology (Japanese version supervised by Takahashi, M.), Tokyo: Soft Science Inc., pp. 135-142.
10. Hasegawa, R., Koizumi, M., Hirose, A. (2004). Principles of risk assessment for determining the safety of chemical: recent assessment of residual solvents in drugs and di(2-ethylhexyl)phthalate. Congenit. Anom. Kyoto 44:51-59.
11. Hirata-Koizumi, M., Watari, N., Mukai, D., Imai, T., Hirose, A., Kamata, E., Ema, M. (2007) A 28-day repeated dose toxicity study of ultraviolet absorber 2-(2′-hydroxy-3′,5′-di-tert-butylphenyl)benzotriazole in rats. Drug Chem. Toxicol. 30:327-341.
12. IARC (International Agency for Research on Cancer). (1995). Peroxisome Proliferation and its Role in Carcinogenesis (Technical Report no. 24). Lyon: IARC Press.
13. Knuckles, M. E., Inyang, F., Ramesh, A. (2004). Acute and subchronic oral toxicity of fluoranthene in F-344 rats. Ecotoxicol. Environ. Saf. 59:102-108.
14. Mann, H. B., Whitney, D. R. (1947). On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18:50-60.
15. METI (Ministry of Economy, Trade and Industry of Japan). (2006). 2-(2H-1,2,3-Benzotriazole-2-yl)-4,6-di-tert-butylphenol, document distributed in Committee on Safety of Chemical Substances, Chemical Substances Council, 30 June 2006. Accessed on April 25, 2007 from http://www.meti.go.jp/ committee/materials/g60705aj.html.
16. MHLW (Ministry of Health, Labour and Welfare of Japan). (2003). 2-(2′-Hydroxy-3′,5′-de-tert-butylphenyl)benzotriazole. In Toxicity Testing Reports of Environmental Chemicals (Ministry of Health, Labour and Welfare, ed.), Vol. 10. Tokyo: Chemicals Investigation Promoting Council, pp. 215-247.
17. MHLW (Ministry of Health, Labour and Welfare of Japan). (2006). 2-(2′-Hydroxy-3′,5′-de-tert-butylphenyl)benzotriazole. In Toxicity Testing Reports of Environmental Chemicals (Ministry of Health, Labour and Welfare, ed.), Vol. 13, Tokyo: Chemicals Investigation Promoting Council, pp. 187-202.
18. OECD (Organization for Economic Co-operation and Development). (1981). Guideline 452, Chronic Toxicity Studies (adopted 12th May 1981), OECD Guidelines for the Testing of Chemicals, section 5, OECD, Paris.
19. OECD (Organization for Economic Co-operation and Development). (1998). Principles on Good Laboratory Practice (as revised in 1997), OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No. 1, OECD, Paris.
20. Steel, R. D. (1959). A multiple comparison rank sum test: treatment versus control. Biometrics 15:560-572.
21. Tenkazai.com. (2007). Market Trend of Resin Additives "Light Stabilizer." Accessed on April 25, 2007 from http://www.tenkazai.com/ market.html.
22. Wang, R. H., Schorer-Apelbaum, D., Weinstock, M. (2001). Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine. Eur. J. Pharmacol. 433:73-79.